In order to bring you the best possible user experience, this site uses Javascript. If you are seeing this message, it is likely that the Javascript option in your browser is disabled. For optimal viewing of this site, please ensure that Javascript is enabled for your browser.
Did you know that your browser is out of date? To get the best experience using our website we recommend that you upgrade to a newer version. Learn more.
ESC Webinar on Acute Pulmonary Embolism
Watch the webinar recording

Acute Pulmonary Embolism (Diagnosis and Management of)

ESC Clinical Practice Guidelines

Venous Thromboembolism
Acute Cardiac Care
Guidelines version available to download
Published in2014
ReferenceEur Heart J doi:10.1093/eurheartj/ehu283
Published in2015
Published in2015
Published in2014
ReferenceWeb Addenda
Published in2014
ReferenceCME Questions - Acute Pulmonary Embolism
Published in2014
Reference2014 Take Home Messages & Gaps in Evidence
Published in2014
ReferenceESC Pocket Guidelines on Acute Pulmonary Embolism
  • PDA
  • Published in2014
    ReferenceAcute PE Mobile App with interactive tools
    Published in2014
    Reference40 Slides on Acute PE
    Table of contents: Full Text (ESC Clinical Practice Guidelines)


    • Epidemiology
    • Predisposing factors
    • Natural history
    • Pathophysiology
    • Clinical classification of pulmonary embolism severity


    • Clinical presentation
    • Assessment of clinical probability
    • D-dimer testing
    • Computed tomographic pulmonary angiography
    • Lung scintigraphy
    • Pulmonary angiography
    • Magnetic resonance angiography
    • Echocardiography
    • Compression venous ultrasonography
    • Diagnostic strategies
      • Suspected pulmonary embolism with shock or hypotension
      • Suspected pulmonary embolism without shock or hypotension        

    Prognostic assessment

    • Clinical parameters
    • Imaging of the right ventricle by echocardiography or computed tomographic angiography
    • Laboratory biomarkers
      • Markers of right ventricular dysfunction 
      • Markers of myocardial injury   
      • Other laboratory biomarkers        
    • Combined modalities and scores
    • Prognostic assessment strategy

    Treatment in the acute phase

    • Haemodynamic and respiratory support
    • Anticoagulation        
      • Parenteral anticoagulation
      • Vitamin K antagonists
      • New oral anticoagulants
    • Thrombolytic treatment         
    • Surgical embolectomy
    • Percutaneous catheter-directed treatment
    • Venous filters
    • Early discharge and outpatient treatment
    • Therapeutic strategies
      • Pulmonary embolism with shock or hypotension (high-risk pulmonary embolism)
      • Pulmonary embolism without shock or hypotension (intermediate- or low-risk pulmonary embolism)

    Duration of anticoagulation

    • New oral anticoagulants for extended treatment

    Chronic thromboembolic pulmonary hypertension

    • Epidemiology
    • Pathophysiology
    • Clinical presentation and diagnosis
    • Treatment and prognosis

    Specific problems

    • Pregnancy
      • Diagnosis of pulmonary embolism in pregnancy
      • Treatment of pulmonary embolism in pregnancy
    • Pulmonary embolism and cancer
      • Diagnosis of pulmonary embolism in patients with cancer
      • Prognosis of pulmonary embolism in patients with cancer
      • Management of pulmonary embolism in patients with cancer
      • Occult cancer presenting as unprovoked pulmonary embolism
    • Non-thrombotic pulmonary embolism
      • Septic embolism
      • Foreign-material pulmonary embolism
      • Fat embolism
      • Air embolism
      • Amniotic fluid embolism
      • Tumour embolism





    Back to top
    European Society
    of Cardiology

    Les Templiers
    2035 Route des Colles
    CS 80179 BIOT
    06903 Sophia Antipolis
    Cedex France